Cost Effectiveness Model for Sweden

Health economics is becoming increasingly important for establishing the role of medicines in osteoporosis. The model has been developed for Sweden by i3 Innovus, Sweden (formerly European Health Economics).

The purpose of the model is to serve as a tool for assessing the cost-effectiveness of the treatment and prevention of osteoporosis. In particular the model is intended to be used for the evaluation of health care technologies affecting the risk of fracture. It can also be used for validating existing and new models.

Download the model and a description by clicking on the links below.


The model has been described in a 2007 position paper of the IOF, written by Zethraeus et al.